Get the Stockscreener App
2.525
2.51%
-0.065
Xbiotech Inc stock is traded at $2.525, with a volume of 41,692.
It is down -2.51% in the last 24 hours and up +16.90% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$2.59
Open:
$2.59
24h Volume:
41,692
Relative Volume:
0.41
Market Cap:
$76.98M
Revenue:
$4.01M
Net Income/Loss:
$-38.53M
P/E Ratio:
-2.004
EPS:
-1.26
Net Cash Flow:
$-32.27M
1W Performance:
+10.75%
1M Performance:
+16.90%
6M Performance:
-14.12%
1Y Performance:
-61.15%
1-Day Range:
$2.44
$2.59
1-Week Range:
$2.26
$2.59
52-Week Range:
$2.09
$7.24
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.525 | 78.96M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Is XBiotech Inc. (4XB) stock a top hedge fund pickMarket Sentiment Review & Precise Buy Zone Identification - Newser
Will XBiotech Inc. (4XB) stock announce a stock split2025 Volatility Report & Safe Capital Preservation Plans - Newser
Why XBiotech Inc. (4XB) stock gets analyst attentionMarket Movers & Community Driven Trade Alerts - Newser
Will XBiotech Inc. (4XB) stock attract long term capital inflows2025 Technical Overview & Smart Investment Allocation Tips - Newser
Why XBiotech Inc. stock appeals to analysts2025 Major Catalysts & Daily Stock Trend Reports - Newser
Will XBiotech Inc. (4XB) stock outperform foreign stocks2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
Is XBiotech Inc. (4XB) stock supported by strong fundamentalsQuarterly Market Summary & Weekly Stock Breakout Alerts - Newser
What analysts say about XBiotech Inc stockStraddle and Strangle Trades & Free Trend Following Techniques - earlytimes.in
Is XBiotech Inc. stock a top momentum playJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Will XBiotech Inc. (4XB) stock benefit from mergersWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Will XBiotech Inc. stock attract ESG investorsProduct Launch & Verified Momentum Stock Alerts - newser.com
What risks investors should watch in XBiotech Inc. stockWeekly Volume Report & Short-Term High Return Strategies - newser.com
Will XBiotech Inc. stock benefit from infrastructure spendingMarket Volume Summary & Weekly High Conviction Ideas - newser.com
Chart based exit strategy for XBiotech Inc.Weekly Gains Report & Expert Approved Trade Ideas - newser.com
Will earnings trigger a reversal in XBiotech Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - newser.com
How high can XBiotech Inc. stock goPortfolio Value Summary & Long-Term Growth Plans - newser.com
Is XBiotech Inc. stock near bottom after declineJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
How to escape a deep drawdown in XBiotech Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
How strong is XBiotech Inc. stock balance sheetQuarterly Profit Summary & Weekly High Return Forecasts - newser.com
Is XBiotech Inc. (4XB) stock expanding market penetration2025 Price Targets & High Return Stock Watch Alerts - newser.com
Earnings visualization tools for XBiotech Inc.Swing Trade & Accurate Intraday Trading Signals - newser.com
Can XBiotech Inc. stock outperform in 2025 bull marketWeekly Investment Recap & Reliable Breakout Forecasts - newser.com
Will XBiotech Inc. stock continue upward momentumJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Will XBiotech Inc. stock go up soonWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):